How long is cosentyx's impact on vaccine effectiveness?

How long does Cosentyx (secukinumab) affect vaccine effectiveness?

Cosentyx (secukinumab) is an IL‑17A inhibitor used for conditions like psoriasis and psoriatic arthritis. The information provided here does not state how long treatment affects vaccine effectiveness.

Does Cosentyx reduce vaccine protection while you’re on it?

The supplied material does not include any findings about whether Cosentyx lowers vaccine-induced antibody levels or protection against infection, either during treatment or after dosing.

What’s the timeline after stopping Cosentyx—does vaccine effectiveness rebound?

No data is included here about durability of any vaccine-related changes after discontinuing Cosentyx, including timing for recovery of vaccine effectiveness.

Does the answer differ by vaccine type (e.g., flu vs COVID-19)?

The provided information does not break out vaccine effectiveness timing by vaccine type.

Are there any guidance on timing vaccines around Cosentyx doses?

No scheduling or guidance content is included in what’s been provided.

If you share the specific source text you want me to use (or the trial/guideline name), I can extract the exact “how long” timeframe from it.